Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does ALlopurinol Regress lefT Ventricular Hypertrophy in End Stage REnal Disease: The ALTERED Study

NCT01951404 is registered in ClinicalTrials.gov with University of Dundee as lead sponsor.

NCT NCT01951404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01951404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does ALlopurinol Regress lefT Ventricular Hypertrophy in End Stage REnal Disease: The ALTERED Study
Lead sponsor
University of Dundee
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2013
Completion date
August 31, 2016
Enrollment
80 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

end stage renal disease, left ventricular hypertrophy